News

Genoskin & LEO Pharma publish data on inflammation model InflammaSkin® in Experimental Dermatology Genoskin’s amazing team of experts is always developing new and improved ex vivo human skin assays. This time, we partnered with LEO Pharma to develop a brand new inflammation model: InflammaSkin®. Genoskin is proud to announce that its unique skin assay is now fully described in ExperimentalRead more

Pharma's Almanac: Overcoming skin assays challenges with living human skin models Genoskin’s CEO, Pascal Descargues was asked to contribute to the next issue of Pharma’s Almanac. It’s increasingly critical for pharmaceutical companies to develop drugs faster and more efficiently. In this article, Pascal gives some insights into how living human skin models help accelerate research.  For decades, the norm forRead more

Genoskin launches new skin offering, NativeSkin® access, that increases accessibility to animal testing alternatives NativeSkin, the only ex vivo human skin model sold online, will be available to purchase daily at a key price point, making it easier to order even for larger volume sales Toulouse, France & Salem, MA, USA, September 1, 2020 - Genoskin, a biotechnology company developing ready-to-use human skinRead more

Genoskin’s CEO invited to talk at Empowered Patient Podcast A window into the latest innovations in health Empowered Patient Podcast started in 2014 to provide its audience with insights on “the latest innovations in digital health and the changing dynamic between doctors and patients.” The audience is composed of researchers, medical professionals, patient advocates, entrepreneurs, patients, caregivers, solution providers, students,Read more

(Virtually) Meet with Genoskin at BIO Digital 2020! From June 8 to 12, Genoskin will be participating in the brand new version of BIO International Convention, BIO Digital 2020. The new digital version of the BIO will welcome online more than 5,000 biotech and pharma professionals from over 55 countries. It's the most international edition to date! Thanks to theRead more

Genoskin selected for Round 2 of Mass Challenge Switzerland 2020! A few weeks ago, Genoskin entered the 2020 Mass Challenge Switzerland. We are now excited to announce that our company is moving on to Round 2 judging! Genoskin has been invited to participate in Round 2 judging of the Mass Challenge Switzerland on May 14th. Our Chief Commercial Officer, EricRead more